These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8846226)
21. NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors. Rogers JP; Luginbühl P; Shen GS; McCabe RT; Stevens RC; Wemmer DE Biochemistry; 1999 Mar; 38(13):3874-82. PubMed ID: 10194298 [TBL] [Abstract][Full Text] [Related]
22. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898 [TBL] [Abstract][Full Text] [Related]
23. Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3). Yamada T; Kidera A FEBS Lett; 1996 May; 387(1):11-15. PubMed ID: 8654558 [TBL] [Abstract][Full Text] [Related]
24. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. Senn H; Klaus W J Mol Biol; 1993 Aug; 232(3):907-25. PubMed ID: 8355277 [TBL] [Abstract][Full Text] [Related]
25. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259 [TBL] [Abstract][Full Text] [Related]
26. Identification of a contact domain between echistatin and the integrin alpha(v)beta(3) by photoaffinity cross-linking. Scheibler L; Mierke DF; Bitan G; Rosenblatt M; Chorev M Biochemistry; 2001 Dec; 40(50):15117-26. PubMed ID: 11735394 [TBL] [Abstract][Full Text] [Related]
27. Critical residues for ligand binding in blade 2 of the propeller domain of the integrin alphaIIb subunit. Tamura T; Hato T; Yamanouchi J; Fujita S Thromb Haemost; 2004 Jan; 91(1):111-8. PubMed ID: 14691576 [TBL] [Abstract][Full Text] [Related]
28. Photomodulation of conformational states. IV. Integrin-binding RGD-peptides with (4-aminomethyl)phenylazobenzoic acid as backbone constituent. Milbradt AG; Löweneck M; Krupka SS; Reif M; Sinner EK; Moroder L; Renner C Biopolymers; 2005 Apr; 77(5):304-13. PubMed ID: 15637699 [TBL] [Abstract][Full Text] [Related]
29. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay. Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891 [TBL] [Abstract][Full Text] [Related]
30. Microenvironmental changes in platelet membranes induced by the interaction of fibrinogen-derived peptide ligands with platelet integrins. Watala C; Gwoźdiński K; Pluskota E; Dzieciatkowska E; Cierniewski CS Eur J Biochem; 1996 Jan; 235(1-2):281-8. PubMed ID: 8631343 [TBL] [Abstract][Full Text] [Related]
31. Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets. Park HS; Kim C; Kang YK Biopolymers; 2002 Apr; 63(5):298-313. PubMed ID: 11877740 [TBL] [Abstract][Full Text] [Related]
32. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin. Choi Y; Kim E; Lee Y; Han MH; Kang IC Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657 [TBL] [Abstract][Full Text] [Related]
33. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902 [TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of a C7 mimetic for the predicted gamma-turn conformation found in several constrained RGD antagonists. Callahan JF; Bean JW; Burgess JL; Eggleston DS; Hwang SM; Kopple KD; Koster PF; Nichols A; Peishoff CE; Samanen JM J Med Chem; 1992 Oct; 35(21):3970-2. PubMed ID: 1433204 [No Abstract] [Full Text] [Related]
36. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041 [TBL] [Abstract][Full Text] [Related]
37. A mutation in the integrin alphaIIb subunit that selectively inhibits alphaIIb beta3 receptor function. Perkins KB; Loftus JC Thromb Haemost; 2003 Nov; 90(5):853-62. PubMed ID: 14597981 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the roles of RGD-binding integrins, alpha(4)/alpha(9) integrins, alpha(6) integrins, and CD9 in the interaction of the fertilin beta (ADAM2) disintegrin domain with the mouse egg membrane. Zhu X; Evans JP Biol Reprod; 2002 Apr; 66(4):1193-202. PubMed ID: 11906941 [TBL] [Abstract][Full Text] [Related]
39. Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa. Lazarus RA; McDowell RS Curr Opin Biotechnol; 1993 Aug; 4(4):438-45. PubMed ID: 7763974 [TBL] [Abstract][Full Text] [Related]